PRVL

Data is currently not available

Prevail Therapeutics Inc. Common Stock (PRVL) Analyst Research

PRVL Analyst Ratings

Data is currently not available
Consensus  

 

Symbol Name Rating

Analyst Firms Making Recommendations

Analyst

Data is currently not available
$0.00

Based on analysts offering 12 month price targets for PRVL in the last 3 months. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Sign in to your SmartPortfolio to see more analyst recommendations.

High $
Avg. $
Low $

Analyst price targets provided by TipRanks.